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Is Dupuytren’s disease really a ‘disease
of the Vikings’?
Michael Ng1, Daniel J Lawson2, Bruce Winney3 and
Dominic Furniss1,4
Abstract
It has been suggested that Dupuytren’s disease has an origin in Norse countries. We harnessed data from a
genome-wide association study of Dupuytren’s disease and the People of the British Isles study to determine
evidence for a Norse origin of Dupuytren’s disease. We computed Wright’s Fixation Index between Orkney
(Norse ancestry), Wales (ancient British) and South East England (Anglo-Saxons); compared mean Wright’s
Fixation Index in cases versus controls; used permutation to determine any excess of Norse inheritance in
disease associated variants; constructed a genetic risk score for Dupuytren’s disease and applied this to the
People of the British Isles dataset to look for systematic differences between counties with known high and
low levels of Norse ancestry. Finally, chromosome painting was used to see whether Dupuytren’s disease-
associated single nucleotide polymorphisms are geographically structured. In all analyses, no evidence was
found for an excess of Norse ancestry in Dupuytren’s disease. We conclude that there is no genetic evidence
for a ‘Viking origin of Dupuytren’s disease’.
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Introduction
Dupuytren’s disease (DD) is a disease of the palmar
fascia that causes flexion contractures of the fingers
(Townley et al., 2006). It is the most common inherited
disease of the connective tissue and its prevalence is
increasing (Bebbington and Furniss, 2015). DD is a
typical complex disease (Hart and Hooper, 2005). To
date, genome-wide association studies (GWAS) have
revealed 26 loci predisposing to DD (Dolmans et al.,
2011; Ng et al., 2017). These associations have
revealed several novel pathophysiological insights
and the risk alleles correlate with recurrence of DD
after surgery (Riesmeijer et al., 2019).
It has been suggested that DD is a ‘disease of the
Vikings’ (Flatt, 2001). The evidence for this assertion
comes from two main themes. First, epidemiological
studies have shown that DD is more common in
European populations and the prevalence seems to
be highest in Iceland and Scandinavian countries that
were the origin of the Viking Warriors (Hindocha
et al., 2009). However, other evidence indicates a
substantial prevalence of DD in countries never
affected by Viking invasions, such as Japan, Spain,
Ethiopia and India (Dasgupta and Harrison, 1996;
Egawa et al., 1990; Gebereegziabher et al., 2017;
Guitian, 1988) although clearly, with increasing
global migration, admixture of populations is occur-
ring with increasing frequency. The second stream of
evidence is historical. Whaley and Elliot (1993) pro-
vided an account of four ‘miracles’ from Nordic
sources, where a condition resembling DD was alle-
viated by miracle cures. Furthermore, the lack of
description of a disease resembling DD in Ancient
Greek, Roman, Early Anglo-Saxon or Medieval
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European writings is further putative evidence of a
Nordic origin of the disease (Elliot, 1988).
The People of the British Isles (PoBI) Study
sampled DNA from 2039 individuals throughout
rural areas of the UK whose four grandparents
were born within 80 km of each other (Winney et al.,
2012). This strategy allowed investigators to effect-
ively sample the grandparental DNA from rural Great
Britain in the latter part of the nineteenth century,
before the start of the major population movements
of the twentieth century. These data have provided
evidence of fine-scale population structure within
the UK. Within the UK there are geographical popu-
lation clusters that can be separated on the basis of
their inherited genetic variation (Leslie et al., 2015).
There are three major historical sources of this
population structure: north-west Germany, France
and Spain, with the greatest contribution observed
in the current population of rural Wales; northern
Germany and Denmark, with the greatest contribu-
tion observed in the population of rural south-east
England; and the Norse, with the greatest contribu-
tion observed in the population of the Orkney Islands.
The most commonly used measure of genetic dif-
ference between populations is Wright’s Fixation
Index (FST) (Hudson et al., 1992). The higher the
index for a particular single nucleotide polymorphism
(SNP), the more different the allele frequencies of
the SNP are between populations. We used recently
reported genetic association results from the British
Society for Surgery of the Hand Genetics of
Dupuytren’s Disease (BSSH-GODD) (Ng et al., 2017)
to provide empirical evidence to investigate whether
DD is associated with Norse ancestry.
Methods
See Table 1 for an explanation of the terms used in
this study.
Cohorts
The recruitment, genotyping, imputation and analysis
methods for the BSSH-GODD and PoBI studies have
been previously described (Leslie et al., 2015; Ng
et al., 2017). Briefly, the BSSH-GODD study included




There are approximately 3 billion base pairs in the human genome. In our species as
a whole, there are variations described at around 75 million of these bases. Each
individual carries around 10 million variants. The vast majority of these variations
are substitutions of single bases (e.g. cytosine becomes guanine – C to G). This
type of variant is known as a single nucleotide polymorphism (SNP) – literally
single nucleotides of multiple form.
Genome wide associ-
ation study (GWAS)
In order to discover genetic variants that are associated with a particular disease,
hundreds of thousands of SNPs across the whole genome carried by thousands of
cases are compared with those carried by thousands of controls. Any SNPs that
are statistically more frequent in cases are said to predispose to disease, and any
that are statistically more frequent in controls are said to protect from disease.
These results give a clue as to the biology of the disease.
Genetic association
results
The results of a GWAS – put simply, which SNPs are associated with an increased or
decreased predisposition to a particular disease.
Wright’s fixation index
(FST)
Different sub-populations within the human species systematically differ from each
other in the frequency of genetic variants across the genome. This is known as
population structure. It can be measured between populations (e.g. European
versus Asian), or within populations (e.g. different regions of the British Isles).
Wright’s Fixation Index (FST) is a measure of how much of the difference between
two sub-populations is due to genetic factors.
Chromosome painting SNPs that are physically close to each other on chromosomes are more likely to be
inherited together than those that are far away, as the latter may be separated by
recombination during meiosis. Therefore, adjacent SNPs can be joined in ‘chunks’
of DNA. Chromosome painting is a method of assigning the SNPs within a dataset
to ‘chunks’ of linked SNPs across a population. These chunks containing
Dupuytren’s Disease-associated variants can then be analysed to see if they are
more commonly shared within a population (e.g. from Orkney, implying a Norse
inheritance around the variant) or between populations (e.g. Orkney versus Wales,
implying no Norse inheritance)
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a total of 7912 cases of DD and 12,937 population-
based controls. The PoBI dataset consisted of a geo-
graphically diverse sample of 2039 individuals from
the United Kingdom, which were then compared with
6209 individuals from across Europe to generate sig-
nals of historical demographic shifts. We identified
the common SNPs between the PoBI dataset and
BSSH-GODD dataset and removed multi-allelic
SNPs and non-autosomal SNPs, leaving a set of
462,930 SNPs for further analysis.
FST analyses
FST for each SNP was calculated using Hudson’s esti-
mator of FST (Hudson et al., 1992), as implemented in
EIGENSOFT (https://www.hsph.harvard.edu/alkes-
price/software/) For each analysis, FST was calcu-
lated between three comparator groups: Orkney vs
Wales, Orkney vs South East, and Orkney vs com-
bined Wales and South East. Because we were inter-
ested in those SNPs that differentiated Orkney from
the other populations, all negative FST values were
set to zero (Garagnani et al., 2009).
First, we compared the summed total FST for
Norse ancestry informative markers from PoBI in
cases and controls in BSSH-GODD. We hypothesized
that if DD were of Norse origin, cases would have a
higher average total FST than controls. For the case-
control analysis, the total genomic FST was calcu-






where n is the Norse-associated allele, X is the FST of
that allele and Y is the number of copies of that allele
in a particular individual. We then compared the dif-
ference between the mean genomic FST of cases and
controls using Welch’s two sample t-test.
Second, the total FST of the DD-associated SNPs
from BSSH-GODD was calculated and compared
with the total FST of 10,000 randomly generated
permutations of SNP groups of the same size, to gen-
erate an empirical p-value for the ‘Viking origin’ of DD-
associated SNPs. We hypothesized that if DD were of
Norse origin, the total FST our associated SNPs would
be in the top 5% of the ranked total FST for the random
permutations of SNPs (nominally p< 0.05).
For the permutation analysis, we first determined
the SNPs to represent each of the 26 credible sets
associated with DD. The PoBI dataset was searched
for the statistically most highly associated SNP from
each credible set. If the most highly associated SNP
from a credible set was not present in the PoBI data-
set, we searched sequentially for the next most asso-
ciated SNP, continuing until a representative variant
was found, or all variants in a 99% credible set were
exhausted. For five credible sets, there was no rep-
resentative SNP in the PoBI dataset (lead SNPs:
rs117402009, rs2472141, rs1042704, rs61982174,
rs34088184), meaning there were 21 DD-associated
SNPs remaining for analysis.
Total FST of the remaining 21 DD-associated SNPs
was calculated, using each of the three comparator
groups. We then permuted 10,000 random sets of 21
SNPs within the PoBI dataset and calculated the total
FST of each of these sets in each of the three com-
parator groups. The permuted sets of random SNPs
were ranked by total FST and we examined where in
this list the set of DD-associated SNPs was ranked.
A nominal threshold of significance of 0.05 was set,
with the hypothesis that if DD is associated with
Norse ancestry, the total FST of the DD-associated
SNP set would be in the top 5% of permuted sets.
Chromosome painting
Next, to assess for localized population structure at
the DD-associated loci in the PoBI dataset, we used
chromosome painting, comparing the frequency of
haplotypes most recently shared within population
groups to that between population groups (Lawson
et al., 2012). The haplotype structure of PoBI partici-
pants at relevant loci was examined. The local paint-
ing for the 21 independent Dupuytren’s GWAS hits
was extracted and the frequency for which individuals
with each population label shared a most recent
haplotype with individuals of each other population
was calculated, to form a population co-ancestry
matrix for each position in the genome. We hypothe-
sized that if DD was caused in individuals by having
Norse ancestry at these loci, then we would expect
that they have an excess amount of local structure,
relative to the genome as a whole. The hypothesis
was tested by comparing the within-population co-
ancestry to the mean outside-population co-ancestry,
by computing the relative frequency of sharing
ancestry within a population to that of sharing ances-
try with an individual from a different population. To
make a fair null hypothesis, we sampled the same
number of random genome-wide SNPs that make up
the risk score using 500 random samples of 21 SNPs.
To ensure that this method has power, we selected a
positive control by repeating this analysis for a
Lactase-associated SNP – rs4988235 in MCM6.
Lactase is under positive selection and there-
fore has much less population-specific haplotype
sharing.
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Genetic risk score
Finally, we constructed a genetic risk score (GRS) for
DD and applied it to the PoBI dataset, hypothesizing
that people from those regions of known high Norse
ancestry would have a higher GRS than those from
areas with low levels of Norse ancestry. The GRS for
DD from the 21 independent Dupuytren’s GWAS hits
was calculated for each individual in the PoBI data-
set. We then aggregated these scores across the 35
population labels to investigate possible geograph-
ical structure associated with known regions of
high Norse ancestry, such as the Highlands of
Scotland.
Data availability
Data used in this study are available from the
European Genome-Phenome Archive (https://ega-




The distribution of genomic FST in both cases and
controls closely followed a normal distribution





































Figure 1. Wright’s Fixation Index (FST) analysis reveals no evidence of a Norse origin of Dupuytren’s Disease (DD). (a) The
mean genomic FST of cases and population controls is not significantly different. The entire cohort was plotted against
theoretical quantiles to demonstrate the normality of the data (upper right panel). (b,c,d) Comparison of total FST for DD-
associated single nucleotide polymorphisms (SNPs; blue line) compared with randomly permuted sets of SNPs. (b) Orkney
vs Wales; (c) Orkney vs South East; (d) Orkney vs Wales and South East.
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between cases and controls ranged between 0.06
and 0.05 (Table 2). For all comparator groups, the
95% confidence intervals of the difference between
means crossed zero meaning there was no signifi-
cant difference. If DD were of Norse origin, we would
expect that cases would have a higher average total
FST than controls.
Permutation analysis
For each comparator group, the total FST of the DD-
associated SNPs was not within the top 5% of
ranked total FST of 10,000 permuted SNP groups
(nominally p> 0.05, Figure 1(b,c,d). In Orkney vs
Wales, the DD-associated set was on the 74th cen-
tile; in Orkney vs South East, it was on the 81st
centile; and in Orkney vs Wales and South East, it
was on the 92nd centile. If DD were of Norse origin,
we would expect that the total FST of our disease-
associated SNPs would be higher than randomly
generated groups of SNPs.
Chromosome painting
Compared with 500 random samples of 21 SNPs
taken from across the genome, the DD-associated
SNPs do not show an increase in within-population
structure (p¼ 0.072, Figure 2(a)), which would have
been expected had DD been associated with Norse
ancestry. This is contrast to the lactase-associated
SNP rs4988235, which as expected shows a highly
significant decrease in population-specific haplotype
sharing (p< 0.001, Figure 2(b)).
Genetic risk score
The aggregated GRS across the PoBI dataset does
not show any geographical clustering in areas of
known high Norse ancestry (Figure 2(c)), which
would have been expected if the genetic predispos-
ition to DD was derived from Norse ancestry. The
95% confidence intervals for each region overlap,
consistent with the notion that DD and Norse ances-
try do not cluster together.
Discussion
Our results do not provide support for the hypoth-
esis that DD is a ‘disease of the Vikings’. We found
no evidence for an excess of Norse ancestry inform-
ative markers in our cases and the total FST of dis-
ease-associated SNPs was not in the top 5% of
10,000 randomly permuted SNP groups of the
same size.
Furthermore, chromosome painting did not find
evidence for localized genetic population structure
that would be expected around DD-associated SNPs
if there were an excess of Norse ancestry. Finally, a
GRS derived from DD-associated SNPs did not show
increased geographical clustering around areas of
known high Norse ancestry. Other phenotypes,
such as educational attainment, show strong asso-
ciations with geography on this scale (Timpson
et al., 2018).
Compared with previous reports (Whaley and
Elliot, 1993), our data provide objective evidence of
the lack of Norse origin of the disease. Some scepti-
cism as to the Norse origin of the disease has been
expressed by Elliot (1988). He commented on the fact
that ‘It is surprising that no earlier reference to this
condition has been found in the Scandinavian litera-
ture’. He also makes reference to both the ‘fragmen-
tary nature of the record which has survived’ and the
fact that life expectancy in previous centuries was
much lower than the median age of onset of DD;
these are both pertinent points that reveal the weak-
ness of the historical case. Furthermore, Elliot (1988)
also comments on the lack of records of DD in the
medical writings of the missionaries of Iona, the
Roman Church in North Germany and North-East
England, or the extensive medical writings from
mediaeval Europe. If DD had been disseminated
around Europe by the Norsemen, mention of it in
one of these sources would be expected. Also,
Hindocha et al., (2009) stated: ‘Other than the
common prevalence of DD in Scandinavia, no object-
ive scientific evidence has been found to date to sup-
port and substantiate the ‘‘Nordic’’ origin of the
disease’.









Orkney vs Wales 480.74 480.69 0.05 (0.22 to 0.12)
Orkney vs South East 319.82 319.88 0.06 (0.05 to 0.17)
Orkney vs Wales and South East 325.17 325.19 0.02 (0.07 to 0.10)
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In conclusion, our genetic analyses directly
contradict the widely held belief, especially popular
among patients, that DD is a disease of Norse origin.
Acknowledgements The authors wish to acknowledge
all of the individuals who participated in both studies. In
addition, we thank the surgeons and researchers in the
BSSH-GODD study who helped with recruitment of affected
individuals.
Declaration of conflicting interests The authors
declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this
article.
Figure 2. Local haplotype structure does not support a Viking introgression of Dupuytren’s disease into the British Isles.
(a) Dupuytren’s genetic risk score is not significantly different from random in a haplotype-based test for population
structure. (b) Lactase-associated SNP rs4988235 shows a highly significant decrease in local haplotype sharing. Lactase
is under positive selection and therefore is expected to show much less population-specific haplotype sharing, and is
therefore a positive control in this analysis. (c) Dupuytren’s genetic risk scores are not associated with geography. When a
genetic risk score is averaged over the 35 counties of the UK, there is no structure, even in areas with high Viking ancestry
such as Orkney (Northernmost population).
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